Fludarabine, Cytarabine, G-CSF and Gemtuzumab Ozogamicin (FLAG-GO) Regimen Results in Better Molecular Response and Relapse-Free Survival in Core Binding Factor Acute Myeloid Leukemia Than FLAG and Idarubicin (FLAG-Ida)

被引：14

作者：

Borthakur, Gautam M. ^{[1
]}

Cortes, Jorge E. ^{[1
]}

Ravandi, Farhad ^{[1
]}

Garcia-Manero, Guillermo ^{[1
]}

Kadia, Tapan M. ^{[1
]}

Jabbour, Elias ^{[1
]}

Patel, Keyur ^{[2
]}

Issa, Ghayas C. ^{[3
]}

Daver, Naval G. ^{[1
]}

Ohanian, Maro N. ^{[1
]}

Brandt, Mark ^{[1
]}

Kantarjian, Hagop M. ^{[4
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX USA

[3] Univ Texas Houston, Houston, TX USA

[4] MD Anderson Canc Ctr, Houston, TX USA

来源：

关键词：

D O I：

10.1182/blood-2019-126014

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

290

引用

页数：5